1. Home
  2. HBB vs RVPHW Comparison

HBB vs RVPHW Comparison

Compare HBB & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$17.00

Market Cap

226.4M

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPHW

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.00

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
RVPHW
Founded
1904
2018
Country
United States
United States
Employees
N/A
14
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
226.4M
N/A
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
HBB
RVPHW
Price
$17.00
$0.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.4K
22.4K
Earning Date
11-05-2025
03-14-2025
Dividend Yield
2.88%
N/A
EPS Growth
24.53
N/A
EPS
2.34
N/A
Revenue
$607,430,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$0.13
52 Week High
$21.20
$0.15

Technical Indicators

Market Signals
Indicator
HBB
RVPHW
Relative Strength Index (RSI) 61.57 23.38
Support Level $16.10 $0.01
Resistance Level $17.23 $0.01
Average True Range (ATR) 0.79 0.00
MACD 0.03 0.00
Stochastic Oscillator 77.88 0.00

Price Performance

Historical Comparison
HBB
RVPHW

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: